Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma
about
Overview of current immunotherapeutic strategies for gliomaMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesAntibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsPharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cellsControlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma TreatmentImmunocompetent murine models for the study of glioblastoma immunotherapyVirally and physically transgenized equine adipose-derived stromal cells as a cargo for paracrine secreted factors.Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.Concise review: stem cells as an emerging platform for antibody therapy of cancer.New therapeutic approaches for malignant glioma: in search of the Rosetta stoneThe art of gene therapy for glioma: a review of the challenging road to the bedsideTumor microenvironment in the brainCancer stem cells and therapeutic targets: an emerging field for cancer treatmentNanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapyEGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.Genetic therapy for the nervous system.Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.Therapeutic cell carriers: a potential road to cure glioma.Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.Stem cell-based therapies for cancer treatment: separating hope from hype.Stem cell in alternative treatments for brain tumors: potential for gene delivery.Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.Stem cell-based therapies for tumors in the brain: are we there yet?EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.Therapeutics formulated to target cancer stem cells: Is it in our future?Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.Targeting Malignant Brain Tumors with Antibodies.Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.Glioblastoma multiforme: can neural stem cells deliver the therapeutic payload and fulfill the clinical promise?
P2860
Q26776345-0F74CDD2-DC19-4E05-9B03-900D84B03BE1Q26799013-4313718C-782C-4DA9-B437-7DACB4282047Q27011298-56335631-0710-4EB5-B4B7-5534CB711DFEQ28540077-533AB76D-1E34-46CD-AEC1-CAA7160B85F5Q28552160-99988585-87E4-4385-8C58-E32AD1220BC0Q33574853-1961CFAE-C7FB-4E53-B729-BE64E49F533FQ33701056-AB3611A7-37FD-4E9B-9430-E134347A11D3Q34240433-EDBE525E-42CE-48FA-9B41-A8B1A05E39FCQ34414838-AA6FF250-C720-414E-B42C-A189D8B8E024Q36224493-00836E5D-FB29-4332-B090-D481A63D0B2DQ36527593-1E7DCA11-F505-4130-8743-4C8824945479Q37016936-13B2BC26-A9A3-4C95-BD8C-95DAC4D6196CQ37200395-F31ADA16-23C4-44D4-B1A4-B597192D0210Q37427886-50E9B455-54B2-4545-A27B-8C8E2BDA2660Q37618652-877CCA4F-F1CB-4AA4-9E98-ADA4F687FA06Q37856565-EE66F713-A1C5-4263-8998-E2F8C4FC914FQ37948053-4089262E-1770-4FAF-B003-EE23DC8FD5C4Q38213836-1B5B2766-8A64-4040-AA80-CCD3F60FFC6EQ38227489-B904860B-3FE3-44AD-B063-B2B019F9FD8EQ38245163-8981C71F-8277-4067-A084-AC3AD0A00632Q38521752-8509956C-4817-4C1D-8C93-00EAB0302597Q38715077-75126555-D845-41F1-BB7E-254934224DE1Q38855638-147A45D2-61B2-445A-B88D-D10928632571Q39677767-E2431B1A-F609-49E2-9CED-358E3050BF0FQ39767667-96B5D1D5-D242-4773-9367-802BB73AB424Q40686919-B6D85395-9D5B-44B3-A4A0-BAFCDB4FA4E8Q42267793-6E9CEBCA-D8D7-4CBD-BD22-B43AF12E4563Q45338034-F614BA3D-7B49-4D3C-9A30-C45137507C30Q48117495-D52A10D1-C46A-4D10-BF91-3F0D95179B13Q54496034-449C0EF1-41BA-434E-9579-06FD2A926F6D
P2860
Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@ast
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@en
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@nl
type
label
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@ast
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@en
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@nl
prefLabel
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@ast
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@en
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@nl
P2093
P2860
P1433
P1476
Mesenchymal stem cells modifie ...... man xenograft malignant glioma
@en
P2093
Irina V Balyasnikova
Maciej S Lesniak
Sadhak Sengupta
Sherise D Ferguson
P2860
P356
10.1371/JOURNAL.PONE.0009750
P407
P577
2010-03-18T00:00:00Z